Christoph Bug is responsible for Veeva’s global medical strategy, working to connect medical affairs more closely with key stakeholders. He previously spent over a decade at Janssen Pharmaceutical Companies of Johnson & Johnson where he was most recently the country medical and scientific lead and managing director for Germany. Earlier Christoph served as director of global market access innovation for Johnson & Johnson R&D in the U.S., business unit director in France and Germany, and director of health economics in EMEA.
Christoph earned his International MBA from IE Business School in Spain and his MD and PhD in medicine at Goethe University in Germany.